| Not Yet Recruiting | Population Pharmacokinetics of Temocillin in Acute Enterobacterial Pyelonephritis in Children NCT07070102 | Assistance Publique - Hôpitaux de Paris | — |
| Active Not Recruiting | Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC) NCT06526884 | University of California, Los Angeles | N/A |
| Completed | Factors and Prognosis of Obstructive Pyelonephritis Patients NCT06299215 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | NRX-101 for Complicated Urinary Tract Infection (UTI) Including Pyelonephritis NCT06128213 | NeuroRx, Inc. | Phase 2 |
| Completed | Plasma NGAL in APN Patients NCT06802796 | Kafrelsheikh University | — |
| Completed | Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urol NCT04594161 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Recruiting | The Validity of the Quick Renal MRI in Pediatric Kidney Disease NCT03959163 | University of Wisconsin, Madison | N/A |
| Completed | Bedside Ultrasonography in Acute Patients With Suspected Kidney Involvement NCT03873701 | Odense University Hospital | — |
| Completed | MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A- NCT03230838 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Treating Pyelonephritis an Urosepsis With Pivmecillinam NCT03282006 | Sykehuset i Vestfold HF | Phase 4 |
| Completed | Management of Sub-Clinical Bacteriuria in Pregnancy NCT03275623 | The University of Texas Health Science Center, Houston | Phase 4 |
| Completed | Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Comp NCT02728089 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Pharmacokinetics of Ciprofloxacin in Pediatric Patients NCT02598362 | University Hospital, Ghent | Phase 4 |
| Completed | Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication NCT02246361 | Floralis | Phase 4 |
| Completed | Effect of Acetylcysteine in Pediatric Acute Pyelonephritis. NCT02080182 | Shahid Beheshti University of Medical Sciences | Phase 2 |
| Completed | Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelo NCT01641029 | Olive View-UCLA Education & Research Institute | — |
| Completed | Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Childr NCT01861353 | University of Oulu | N/A |
| Unknown | Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria NCT01771432 | Núria Sabé Fernàndez | N/A |
| Completed | Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Al NCT01505634 | Merck Sharp & Dohme LLC | Phase 2 |
| Terminated | Prospective Study in the Emergency NCT01628900 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Uri NCT01345929 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 3 |
| Completed | Prognostic Indicators as Provided by the EPIC ClearView NCT01476995 | Epic Research & Diagnostics, Inc. | — |
| Withdrawn | Antibiotic Prophylaxis in Children With Pyelonephritis NCT00752375 | University of Alberta | Phase 3 |
| Completed | Antibiotic Education for Children in an Emergency Care Unit NCT00948779 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Kinetics of Biomarkers in Acute Pyelonephritis NCT00805181 | University Hospital, Geneva | — |
| Terminated | Short-term Antibiotic Therapy for Pyelonephritis in Childhood NCT00724256 | IRCCS Burlo Garofolo | Phase 3 |
| Unknown | Contrast-Enhanced US of Spleen, Liver and Kidney NCT00190281 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old NCT00136656 | Assistance Publique - Hôpitaux de Paris | Phase 4 |
| Completed | Risk Factors for Recurrent Urinary Tract Infection in Children NCT00528476 | Kaunas University of Medicine | — |
| Completed | A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated NCT00210886 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Completed | Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis NCT00210990 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Completed | Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis NCT00229021 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Completed | A Randomized Controlled Trial on Antibiotic Prophylaxis in Children With Vesico-Ureteral Reflux NCT00382343 | IRCCS Burlo Garofolo | Phase 4 |
| Completed | A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment NCT00258089 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |